Christopher K. Murray - Net Worth and Insider Trading

Christopher K. Murray Net Worth

The estimated net worth of Christopher K. Murray is at least $3 Million dollars as of 2024-03-28. Christopher K. Murray is the CHIEF TECHNICAL OPERATIONS of Blueprint Medicines Corp and owns about 33,853 shares of Blueprint Medicines Corp (BPMC) stock worth over $3 Million. Details can be seen in Christopher K. Murray's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher K. Murray has not made any transactions after 2024-03-07 and currently still holds the listed stock(s).

Transaction Summary of Christopher K. Murray

To

Christopher K. Murray Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher K. Murray owns 1 companies in total, including Blueprint Medicines Corp () .

Click here to see the complete history of Christopher K. Murray’s form 4 insider trades.

Insider Ownership Summary of Christopher K. Murray

Ticker Comapny Transaction Date Type of Owner
Blueprint Medicines Corp 2024-03-07 SVP & Technical Operations

Christopher K. Murray Latest Holdings Summary

Christopher K. Murray currently owns a total of 1 stock. Christopher K. Murray owns 33,853 shares of Blueprint Medicines Corp (BPMC) as of March 7, 2024, with a value of $3 Million.

Latest Holdings of Christopher K. Murray

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BPMC Blueprint Medicines Corp 2024-03-07 33,853 94.32 3,193,015

Holding Weightings of Christopher K. Murray


Christopher K. Murray Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher K. Murray has made a total of 8 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Blueprint Medicines Corp is the sale of 2,521 shares on March 7, 2024, which brought Christopher K. Murray around $228,629.

Insider Trading History of Christopher K. Murray

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher K. Murray Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher K. Murray Ownership Network

Ownership Network List of Christopher K. Murray

No Data

Ownership Network Relation of Christopher K. Murray


Christopher K. Murray Owned Company Details

What does Blueprint Medicines Corp do?

Who are the key executives at Blueprint Medicines Corp?

Christopher K. Murray is the SVP & Technical Operations of Blueprint Medicines Corp. Other key executives at Blueprint Medicines Corp include director & CEO & President Jeffrey W. Albers , Principal FAO Michael Landsittel , and Principal Accounting Officer Ariel Hurley .

Blueprint Medicines Corp () Insider Trades Summary

Over the past 18 months, Christopher K. Murray made 6 insider transaction in Blueprint Medicines Corp () with a net sale of 11,217. Other recent insider transactions involving Blueprint Medicines Corp () include a net sale of 175,899 shares made by Jeffrey W. Albers , a net sale of 13,571 shares made by Fouad Namouni , and a net sale of 7,851 shares made by Ariel Hurley .

In summary, during the past 3 months, insiders sold 138,534 shares of Blueprint Medicines Corp () in total and bought 0 shares, with a net sale of 138,534 shares. During the past 18 months, 299,817 shares of Blueprint Medicines Corp () were sold and 1,100 shares were bought by its insiders, resulting in a net sale of 298,717 shares.

Blueprint Medicines Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Blueprint Medicines Corp Insider Transactions

No Available Data

Christopher K. Murray Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher K. Murray. You might contact Christopher K. Murray via mailing address: C/o Blueprint Medicines Corporation, 38 Sidney Street, Suite 200, Cambridge Ma 02139.

Discussions on Christopher K. Murray

No discussions yet.